ÍøºìºÚÁÏ

Skip to main content
(352) 265-5470

Thomas M Beaver, MD, MPH : Research

Cardiovascular Surgeon

Additional languages:
Spanish
Photo of Thomas M Beaver
(352) 265-5470 MyUFÍøºìºÚÁÏ

Research at a glance

Top areas of exploration

  • Aortic Aneurysm, Thoracic , 37 publications
  • Blood Vessel Prosthesis Implantation , 31 publications
  • Postoperative Complications , 29 publications
  • Aorta, Thoracic , 26 publications

Research activity

216 publications

3,399 citations

Why is this important?

Active clinical trials

The PROTECT Study

The purpose of this study is to evaluate the effect of RBT-1 on reducing the risk of post-operative complications in subjects undergoing cardiac surgery on cardiopulmonary bypass (CPB). A sub-study will also be conducted to evaluate the…

Investigator
Thomas M Beaver
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All
ARISE II

The primary objective of ARISE II is to assess the safety and effectiveness of the GORE® Ascending Stent Graft device in the treatment of lesions involving the ascending aorta and aortic arch.

Investigator
Thomas M Beaver
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All
EXPAND II

Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.

Investigator
Thomas M Beaver
Status
Accepting Candidates
Ages
65 Years - N/A
Sexes
All

My publications

216 publications

2023

Commentary: Shades of gray: The right aortic valve for the right patient in 2022.

The Journal of thoracic and cardiovascular surgery

•

2023

Commentary: Thoracic endovascular aortic repair in Marfan syndrome-dancing with dogma.

The Journal of thoracic and cardiovascular surgery

•

2023

Discussion to: False lumen-dependent segmental arteries are associated with spinal cord injury in frozen elephant trunk procedure for acute type I aortic dissection.

JTCVS open

•

2023

Dysphagia after cardiac surgery: Prevalence, risk factors, and associated outcomes.

The Journal of thoracic and cardiovascular surgery

•

2023

Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study-protocol for a phase 3, randomized, controlled trial.

Trials

•